경피적 전기 신경 자극 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 용도별, 최종 용도별, 지역별 예측(2024-2030년)

Transcutaneous Electrical Nerve Stimulation Market Growth & Trends:

The global transcutaneous electrical nerve stimulation market is anticipated to reach USD 419.48 million by 2030, and is expected to grow at a CAGR of 3.94% from 2024 to 2030 according to a new report by Grand View Research, Inc. Rising cases of chronic pain, sports injuries, along with an increasing geriatric population base are some of the major factors driving transcutaneous electrical nerve stimulation market growth. For instance, as per a CDC report, in 2019, 20.4% of adults had chronic pain and 7.4% of adults had high impact chronic pain (limited work activities) in the U.S.

Moreover, the growing preference for TENS among physiotherapists is further aiding in the market growth. Physiotherapists are increasingly shifting their preference from manual techniques to muscle stimulators to treat patients in clinical and at-home settings as they consume less time and are more effective. This is expected to drive the transcutaneous electrical nerve stimulation growth over the forecast period.

The outbreak of COVID-19 in the year 2020 has moderately hampered the market expansion owing to the issues such as the disruption of the medical supply chain, delayed production, and a restricted workforce. However, the introduction of the COVID-19 vaccine, and the lifting of lockdown impositions across the borders, are expected to have a positive impact on the transcutaneous electrical nerve stimulation market in the coming years.

Transcutaneous Electrical Nerve Simulation Market Report Highlights:

• On the basis of product, the TENS market is segmented into portable and tabletop TENS units. In 2023, the portable TENS segment dominated the market due to the growing demand for at-home use devices and the increasing geriatric population, widening the pool of immobile patients.
• On the basis of application, the market is segmented into chronic pain and acute pain. The acute pain segment held the largest share in 2023. Acute pain is further subsegmented into sports injuries, postoperative pain, labor pain, and menstrual pain.
• The North America transcutaneous electrical nerve stimulation market dominated the global market with the largest revenue share of 43.36% in 2023 and is likely to maintain its position over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Transcutaneous Electrical Nerve Stimulation Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising Cases Of Chronic And Acute Pain
    • 3.2.1.2. Ineffectiveness Of Oral Drugs And Low Preference For Surgical Intervention
    • 3.2.1.3. Rising Geriatric Population
    • 3.2.1.4. Rising Demand For Reduced Hospital Stay
    • 3.2.1.5. Increasing Number Of Surgeries
    • 3.2.1.6. Rising Cases Of Anterior Cruciate Ligament (ACL) Tear, Hip Flexor Strain, And Hamstring Strain Among Sports Players
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Adverse Effects Associated With Devices
    • 3.2.2.2. Increased Cost Of Nerve Stimulation Therapy
  • 3.2.3. Market Opportunities Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Transcutaneous Electrical Nerve Stimulation Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Transcutaneous Electrical Nerve Stimulation Market: Product Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Transcutaneous Electrical Nerve Stimulation Market Movement Analysis
• 4.3. Global Transcutaneous Electrical Nerve Stimulation Market Size & Trend Analysis, by Product Type, 2018 to 2030 (USD Million)
• 4.4. Portables Tens
  • 4.4.1. Portables Tens Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Table Top Tens
  • 4.5.1. Table Top Tens Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Transcutaneous Electrical Nerve Stimulation Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Transcutaneous Electrical Nerve Stimulation Market Movement Analysis
• 5.3. Global Transcutaneous Electrical Nerve Stimulation Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Chronic Pain
  • 5.4.1. Chronic Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.2. Arthritis
    • 5.4.2.1 Arthritis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.3 Back & Neck Pain
    • 5.4.3.1 Back & Neck Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.4 Fibromyalgia
    • 5.4.4.1 Fibromyalgia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.5 Neuropathic Pain
    • 5.4.5.1 Neuropathic Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.6 Others
    • 5.4.6.1 Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Acute Pain
  • 5.5.1. Acute Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.2. Sports Injuries
    • 5.5.2.1 Sports Injuries Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.3 Postoperative Pain
    • 5.5.3.1 Postoperative Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.4 Labor Pain
    • 5.5.4.1 Labor Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.5 Menstrual Pain
    • 5.5.5.1 Menstrual Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Transcutaneous Electrical Nerve Stimulation Market: End-use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Transcutaneous Electrical Nerve Stimulation Market Movement Analysis
• 6.3. Global Transcutaneous Electrical Nerve Stimulation Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Physiotherapy Clinics
  • 6.5.1. Physiotherapy Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Rehabilitation Centers
  • 6.6.1. Rehabilitation Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Home Care
  • 6.7.1. Home Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Others
  • 6.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Transcutaneous Electrical Nerve Stimulation Market: Regional Estimates & Trend Analysis By Product Type, By End-use, By Application

• 7.1. Regional Dashboard
• 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 7.3. North America
  • 7.3.1. North America Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Competitive Scenario
    • 7.3.2.3. Regulatory Scenario
    • 7.3.2.4. Reimbursement Scenario
    • 7.3.2.5. U.S. Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Competitive Scenario
    • 7.3.3.3. Regulatory Scenario
    • 7.3.3.4. Reimbursement Scenario
    • 7.3.3.5. Canada Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Scenario
    • 7.4.2.4. Reimbursement Scenario
    • 7.4.2.5. UK Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Scenario
    • 7.4.3.4. Reimbursement Scenario
    • 7.4.3.5. Germany Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Scenario
    • 7.4.4.4. Reimbursement Scenario
    • 7.4.4.5. France Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Competitive Scenario
    • 7.4.5.3. Regulatory Scenario
    • 7.4.5.4. Reimbursement Scenario
    • 7.4.5.5. Italy Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Competitive Scenario
    • 7.4.6.3. Regulatory Scenario
    • 7.4.6.4. Reimbursement Scenario
    • 7.4.6.5. Spain Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.7. Denmark
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Competitive Scenario
    • 7.4.7.3. Regulatory Scenario
    • 7.4.7.4. Reimbursement Scenario
    • 7.4.7.5. Denmark Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key Country Dynamics
    • 7.4.8.2. Competitive Scenario
    • 7.4.8.3. Regulatory Scenario
    • 7.4.8.4. Reimbursement Scenario
    • 7.4.8.5. Sweden Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key Country Dynamics
    • 7.4.9.2. Competitive Scenario
    • 7.4.9.3. Regulatory Scenario
    • 7.4.9.4. Reimbursement Scenario
    • 7.4.9.5. Norway Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Scenario
    • 7.5.2.4. Reimbursement Scenario
    • 7.5.2.5. Japan Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Scenario
    • 7.5.3.4. Reimbursement Scenario
    • 7.5.3.5. China Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Scenario
    • 7.5.4.4. Reimbursement Scenario
    • 7.5.4.5. India Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Scenario
    • 7.5.5.4. Reimbursement Scenario
    • 7.5.5.5. South Korea Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Scenario
    • 7.5.6.4. Reimbursement Scenario
    • 7.5.6.5. Australia Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Scenario
    • 7.5.7.4. Reimbursement Scenario
    • 7.5.7.5. Thailand Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Scenario
    • 7.6.2.4. Reimbursement Scenario
    • 7.6.2.5. Brazil Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. Mexico
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Scenario
    • 7.6.3.4. Reimbursement Scenario
    • 7.6.3.5. Mexico Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. Argentina
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Scenario
    • 7.6.4.4. Reimbursement Scenario
    • 7.6.4.5. Argentina Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Middle East & Africa
  • 7.7.1. Middle East & Africa Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Scenario
    • 7.7.2.4. Reimbursement Scenario
    • 7.7.2.5. South Africa Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Scenario
    • 7.7.3.4. Reimbursement Scenario
    • 7.7.3.5. Saudi Arabia Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Scenario
    • 7.7.4.4. Reimbursement Scenario
    • 7.7.4.5. UAE Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Scenario
    • 7.7.5.4. Reimbursement Scenario
    • 7.7.5.5. Kuwait Transcutaneous Electrical Nerve Stimulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. OMRON CORPORATION
    • 8.2.1.1. Company Overview
    • 8.2.1.2. Financial Performance
    • 8.2.1.3. Service Benchmarking
    • 8.2.1.4. Strategic Initiatives
  • 8.2.2. ZYNEX MEDICAL
    • 8.2.2.1. Company Overview
    • 8.2.2.2. Financial Performance
    • 8.2.2.3. Service Benchmarking
    • 8.2.2.4. Strategic Initiatives
  • 8.2.3. NEUROMETRIX, INC.
    • 8.2.3.1. Company Overview
    • 8.2.3.2. Financial Performance
    • 8.2.3.3. Product Benchmarking
    • 8.2.3.4. Strategic Initiatives
  • 8.2.4. EMS PHYSIO LTD.
    • 8.2.4.1. Company Overview
    • 8.2.4.2. Financial Performance
    • 8.2.4.3. Product Benchmarking
    • 8.2.4.4. Strategic Initiatives
  • 8.2.5. BIOMEDICAL LIFE SYSTEMS
    • 8.2.5.1. Company Overview
    • 8.2.5.2. Financial Performance
    • 8.2.5.3. Product Benchmarking
    • 8.2.5.4. Strategic Initiatives
  • 8.2.6. DJO GLOBAL, INC.
    • 8.2.6.1. Company Overview
    • 8.2.6.2. Financial Performance
    • 8.2.6.3. Product Benchmarking
    • 8.2.6.4. Strategic Initiatives
  • 8.2.7. GLOBUS
    • 8.2.7.1. Company Overview
    • 8.2.7.2. Financial Performance
    • 8.2.7.3. Product Benchmarking
    • 8.2.7.4. Strategic Initiatives
  • 8.2.8. Beacmed s.r.l.
    • 8.2.8.1. Company Overview
    • 8.2.8.2. Financial Performance
    • 8.2.8.3. Product Benchmarking
    • 8.2.8.4. Strategic Initiatives
  • 8.2.9. Iskra Medical d.o.o.
    • 8.2.9.1. Company Overview
    • 8.2.9.2. Financial Performance
    • 8.2.9.3. Product Benchmarking
    • 8.2.9.4. Strategic Initiatives
  • 8.2.10. Ito Co., Ltd.
    • 8.2.10.1. Company Overview
    • 8.2.10.2. Financial Performance
    • 8.2.10.3. Product Benchmarking
    • 8.2.10.4. Strategic Initiatives
• 8.3. Heat Map Analysis/ Company Market Position Analysis
• 8.4. Estimated Company Market Share Analysis, 2023
• 8.5. List of Other Key Market Players